Topics / Thyroid
Focus area
Thyroid
Evidence you can trust. Clinical questions you care about.
Hypothyroidism treatment targets, combination therapy, desiccated thyroid, and thyroid-metabolic questions.
Reviewed by Neal Rouzier, MD, Preventive Medicine · Aug 2026
6 published deep analyses
Featured evidence questions
Top clinical questions
High-priority clinical questions with structured evidence analysis in this focus area.
Should subclinical hypothyroidism be treated with
Should subclinical hypothyroidism be treated with levothyroxine?
The TRUST trial found no meaningful symptom or quality-of-life benefit from levothyroxine in older adults with subclinical hypothyroidism. Treatment may still be considered with very high TSH, pregnancy plans, or specific clinical contexts.
Open deep analysis →
What factors interfere with levothyroxine absorption
What factors interfere with levothyroxine absorption?
Levothyroxine absorption is reduced by concurrent iron, calcium, PPIs, and some foods including coffee and fiber. Consistent fasting dosing separated from interfering substances improves TSH stability.
Open deep analysis →
Is desiccated thyroid extract superior to
Is desiccated thyroid extract superior to levothyroxine for hypothyroidism?
Levothyroxine is standard first-line therapy with the strongest outcome evidence. Desiccated thyroid extract lacks modern RCT data demonstrating superiority and has variable hormone content between batches.
Open deep analysis →
Does treated hypothyroidism fully explain difficulty
Does treated hypothyroidism fully explain difficulty losing weight?
Hypothyroidism can contribute to weight gain, but levothyroxine normalization typically yields modest weight loss rather than resolving obesity. Persistent weight difficulty usually involves additional metabolic and behavioral factors.
Open deep analysis →
Published deep analyses
Evidence map
All published structured analyses in this focus area, with core studies and explainable confidence.
What factors interfere with levothyroxine absorption
What factors interfere with levothyroxine absorption?
Levothyroxine absorption is reduced by concurrent iron, calcium, PPIs, and some foods including coffee and fiber. Consistent fasting dosing separated from interfering substances improves TSH stability.
Open deep analysis →
Should subclinical hypothyroidism be treated with
Should subclinical hypothyroidism be treated with levothyroxine?
The TRUST trial found no meaningful symptom or quality-of-life benefit from levothyroxine in older adults with subclinical hypothyroidism. Treatment may still be considered with very high TSH, pregnancy plans, or specific clinical contexts.
Open deep analysis →
Is desiccated thyroid extract superior to
Is desiccated thyroid extract superior to levothyroxine for hypothyroidism?
Levothyroxine is standard first-line therapy with the strongest outcome evidence. Desiccated thyroid extract lacks modern RCT data demonstrating superiority and has variable hormone content between batches.
Open deep analysis →
Does treated hypothyroidism fully explain difficulty
Does treated hypothyroidism fully explain difficulty losing weight?
Hypothyroidism can contribute to weight gain, but levothyroxine normalization typically yields modest weight loss rather than resolving obesity. Persistent weight difficulty usually involves additional metabolic and behavioral factors.
Open deep analysis →
What TSH target is appropriate for
What TSH target is appropriate for treated hypothyroidism?
Most guidelines suggest maintaining TSH within the reference range on levothyroxine, often near the lower half for many patients. Pregnancy and specific comorbidities require tighter targets.
Open deep analysis →
Does combination T3/T4 therapy improve symptoms
Does combination T3/T4 therapy improve symptoms versus levothyroxine alone?
Randomized trials and meta-analyses show inconsistent symptom benefit from adding liothyronine to levothyroxine compared with levothyroxine monotherapy. Guidelines generally recommend levothyroxine as first-line therapy.
Open deep analysis →
Latest evidence
Recent core studies
Recently published studies linked to evidence analyses in this focus area.
British journal of clinical pharmacology · 2026
Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review.
View study →
Endocrine connections · 2026
Additional treatment strategies for hypothyroidism: a network meta-analysis.
View study →
Frontiers in endocrinology · 2023
Natural desiccated thyroid for the treatment of hypothyroidism?
View study →
Related topics
Explore adjacent focus areas
Explore another focus area or ask a new clinical question grounded in published evidence.